Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 6

Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada Open Access

Abstract

In cases where sputum is non-diagnostic or unavailable, bronchoscopy can yield high-value respiratory samples for tuberculosis (TB) diagnosis. Whilst (MTB) culture remains the gold standard, molecular assays such as Xpert MTB/RIF Ultra (Xpert Ultra) are increasingly being used for rapid diagnosis.

Xpert Ultra is increasingly used for TB diagnosis and has been extensively evaluated on sputum specimens, but assessment of performance on bronchoscopy samples is more limited.

To retrospectively evaluate the performance of Xpert Ultra on bronchoscopy specimens in comparison to culture in a low-incidence, high-resource setting.

Patients with a clinical suspicion of TB, who had non-diagnostic sputum or limited sputum production and underwent bronchoscopy between March 2019 and October 2023, were included in the study. Bronchoscopy specimens comprised bronchoalveolar lavages, bronchial washings and endobronchial ultrasound lymph node tissue biopsies. All included specimens underwent acid-fast bacilli (AFB) smear, mycobacterial culture and Xpert Ultra. Positive MTB culture was considered the reference standard for TB diagnosis.

One hundred thirty-five bronchoscopy samples from 126 patients were included. Cultures were positive for MTB in 47 out of 126 (37.3%) of included patients. Overall, positive percent agreement (PPA) and negative percent agreement (NPA) of Xpert Ultra to MTB culture were 93.6% and 98.7%, respectively. In 19 AFB smear-positive cases, Xpert Ultra had 100% PPA and NPA, whilst in 28 smear-negative cases, PPA and NPA were 89.3% and 98.6%, respectively. On average, positive culture results were available after 15.2 days of incubation (range, 5–42 days) versus 24 h for Xpert Ultra. Xpert Ultra PCR cycle threshold values correlated strongly with AFB-smear grade and time-to-culture positivity.

Xpert Ultra performed on specimens collected via bronchoscopy demonstrated excellent agreement with culture, even in smear-negative cases. Our results support the use of the Ultra on bronchoscopy specimens for accurate and rapid TB diagnosis in a low-incidence setting.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): bronchoscopy , GeneXpert MTB/RIF Ultra and Mycobacterium tuberculosis
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002022
2025-06-06
2025-06-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/6/jmm002022.html?itemId=/content/journal/jmm/10.1099/jmm.0.002022&mimeType=html&fmt=ahah

References

  1. Global tuberculosis report 2022. Geneva: World Health organization; 2022
  2. Tuberculosis Surveillance in Canada Summary Report: 2012-2021. Ottawa: Public Health Agency of Canada; 2023
  3. Pfyffer GE, Wittwer F. Incubation time of Mycobacterial cultures: how long is long enough to issue a final negative report to the clinician?. J Clin Microbiol 2012; 50:4188–4189 [View Article] [PubMed]
     [Google Scholar]
  4. Keeler E, Perkins MD, Small P, Hanson C, Reed S et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 2006; 444 Suppl 1:49–57 [View Article] [PubMed]
     [Google Scholar]
  5. Use of xpert MTB/RIF and xpert MTB/RIF ultra on genexpert 10-colour instruments: WHO policy statement. Geneva: World Health Organization; 2021
  6. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y et al. The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio 2017; 8:e00812-17 [View Article] [PubMed]
     [Google Scholar]
  7. Zifodya JS, Kreniske JS, Schiller I, Kohli M, Dendukuri N et al. Xpert ultra versus xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database Syst Rev 2021; 2:CD009593 [View Article] [PubMed]
     [Google Scholar]
  8. Jiang J, Yang J, Shi Y, Jin Y, Tang S et al. Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis. Infect Dis 2020; 52:763–775 [View Article]
     [Google Scholar]
  9. Slail MJ, Booq RY, Al-Ahmad IH, Alharbi AA, Alharbi SF et al. Evaluation of xpert MTB/RIF ultra for the diagnosis of extrapulmonary tuberculosis: a retrospective analysis in saudi arabia. J Epidemiol Glob Health 2023; 13:782–793 [View Article] [PubMed]
     [Google Scholar]
  10. Theron G, Peter J, Meldau R, Khalfey H, Gina P et al. Accuracy and impact of xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid. Thorax 2013; 68:1043–1051 [View Article] [PubMed]
     [Google Scholar]
  11. Chien JY, Lin CK, Yu CJ, Hsueh PR. Usefulness of Xpert MTB/RIF ultra to rapidly diagnose sputum smear-negative pulmonary tuberculosis using bronchial washing fluid. Front Microbiol 2020; 11:588963 [View Article] [PubMed]
     [Google Scholar]
  12. Martin-Higuera MC, Rivas G, Rolo M, Muñoz-Gallego I, Lopez-Roa P. Xpert MTB/RIF Ultra CT value provides a rapid measure of sputum bacillary burden and predicts smear status in patients with pulmonary tuberculosis. Sci Rep 2023; 13:1591 [View Article] [PubMed]
     [Google Scholar]
  13. Mekkaoui L, Hallin M, Mouchet F, Payen M-C, Maillart E et al. Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium. PLoS One 2021; 16:e0249734 [View Article] [PubMed]
     [Google Scholar]
  14. Santos AP, Silva DR, Delazare G, Rodrigues JG, de Aguiar MCFF et al. Clinical impact of xpert® MTB/RIF ultra for pulmonary TB diagnosis under routine conditions in a reference center in brazil. Pulmonology 2024; 30:75–77 [View Article] [PubMed]
     [Google Scholar]
  15. Tang P, Liu R, Qin L, Xu P, Xiong Y et al. Accuracy of Xpert® MTB/RIF Ultra test for posterior oropharyngeal saliva for the diagnosis of paucibacillary pulmonary tuberculosis: a prospective multicenter study. Emerg Microbes Infect 2023; 12:2148564 [View Article] [PubMed]
     [Google Scholar]
  16. Yao L, Chen S, Sha W, Gu Y. The diagnostic performance of endobronchial ultrasound with xpert MTB/RIF ultra in smear-negative pulmonary tuberculosis. BMC Infect Dis 2023; 23:107 [View Article] [PubMed]
     [Google Scholar]
  17. Liu HC, Gao YL, Li DF, Zhao XY, Pan YQ et al. Value of Xpert MTB/RIF using bronchoalveolar lavage fluid for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. J Clin Microbiol 2021; 59:e02170-20 [View Article] [PubMed]
     [Google Scholar]
  18. Kim YW, Kwon BS, Lim SY, Lee YJ, Cho Y-J et al. Diagnostic value of bronchoalveolar lavage and bronchial washing in sputum-scarce or smear-negative cases with suspected pulmonary tuberculosis: a randomized study. Clin Microbiol Infect 2020; 26:911–916 [View Article] [PubMed]
     [Google Scholar]
  19. Arend SM, van Soolingen D. Performance of xpert MTB/RIF ultra: a matter of dead or alive. Lancet Infect Dis 2018; 18:8–10 [View Article] [PubMed]
     [Google Scholar]
  20. Darwish M, Abd M, Wadood E, Alnagdi H. African journal of microbiology research diagnostic assessment of xpert MTB/RIF in a sample of Mycobacterium tuberculosis egyptian patients; 2013; 75107–5113
  21. Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G et al. Added value of Xpert MTB/RIF ultra for diagnosis of pulmonary tuberculosis in a low-prevalence setting. J Clin Microbiol 2019; 57:e01717-18 [View Article] [PubMed]
     [Google Scholar]
  22. Fennelly KP, Jones-López EC, Ayakaka I, Kim S, Menyha H et al. Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2012; 186:450–457 [View Article] [PubMed]
     [Google Scholar]
  23. Hodille E, Maisson A, Charlet L, Bauduin C, Genestet C et al. Evaluation of Xpert MTB/RIF ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre. Eur J Clin Microbiol Infect Dis 2019; 38:601–605 [View Article] [PubMed]
     [Google Scholar]
  24. Zhang P, Liu H, Wang H, Wu Y, Sun L et al. Performance of Xpert MTB/RIF ultra for the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage samples in people living with HIV/AIDS (PLWHA) in China: a prospective study. HIVAIDS Auckl NZ 2021; Volume 13:905–916 [View Article]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002022
Loading
Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada
J. Med. Microbiol. 74, 002022 (2025); https://doi.org/10.1099/jmm.0.002022
/content/journal/jmm/10.1099/jmm.0.002022
/content/journal/jmm/10.1099/jmm.0.002022
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error